1,3-苯并噻唑-3-鎓-2-基(甲基)亚膦酸酯 | 262603-85-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并噻唑类
• 中文名称: 1,3-苯并噻唑-3-鎓-2-基(甲基)亚膦酸酯
• 英文名称: 1,3-benzothiazol-2-yl(methyl)phosphinic acid
• 英文别名: (1,3-Benzothiazol-2-yl)(methyl)phosphinic acid
• CAS: 262603-85-0
• 化学式: C₈H₈NO₂PS
• 分子量: 213.197
• InChiKey: IMNBCOMVWKPFFK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  82.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  1,3-苯并噻唑-3-鎓-2-基(甲基)亚膦酸酯 在 氯化亚砜 作用下， 反应 6.0h， 生成 1,3-benzothiazol-2-yl(methyl)morpholinophosphine oxide
  参考文献：
  名称：

  Direct Phosphorylation of Benzothiazoles and 4-Methyltthiazole

  摘要：

  Simple procedures for preparation of 2-(4-methylthiazolyl) dichlorophosphine and wide variety of 2-phosphorylated benzothiazoles are reported. Efficient promoters and catalysts were found for the key transformation, direct phosphorylation of the heterocyclic compounds by PCl3 (PBr3 as a promoter) or by P(V) acid chlorides (HgCl2 as a catalyst).

  DOI：

  10.1080/00397910008087315
• 作为产物：
  描述：

  甲基膦酞二氯 、 苯并噻唑 在 三乙胺 、 mercury dichloride 作用下， 以 吡啶 为溶剂， 以73%的产率得到1,3-苯并噻唑-3-鎓-2-基(甲基)亚膦酸酯
  参考文献：
  名称：

  Direct Phosphorylation of Benzothiazoles and 4-Methyltthiazole

  摘要：

  Simple procedures for preparation of 2-(4-methylthiazolyl) dichlorophosphine and wide variety of 2-phosphorylated benzothiazoles are reported. Efficient promoters and catalysts were found for the key transformation, direct phosphorylation of the heterocyclic compounds by PCl3 (PBr3 as a promoter) or by P(V) acid chlorides (HgCl2 as a catalyst).

  DOI：

  10.1080/00397910008087315

文献信息

• Dimethylarginine Dimethylaminohydrolase Inhibitors and Methods of Use Thereof
  申请人：University The Board of Trustees of the Leland Stanford Junior

  公开号：US20130224259A1

  公开（公告）日：2013-08-29

  The present disclosure provides DDAH modulators. Thus, the present disclosure provides a method of treating a patient suffering from a disorder characterized by excessive NO production and/or elevated DDAH activity, the method comprising administering to said patient an effective amount of a compound of one of formulae I-X. The present disclosure also provides a pharmaceutical composition comprising a compound of one of formulae I-X.
• US9011882B2
  申请人：——

  公开号：US9011882B2

  公开（公告）日：2015-04-21
• [EN] DIMETHYLARGININE DIMETHYLAMINOHYDROLASE INHIBITORS AND METHODS OF USE THEREOF<br/>[FR] INHIBITEURS DE DIMÉTHYLARGININE DIMÉTHYLAMINOHYDROLASE ET PROCÉDÉS D'UTILISATION ASSOCIÉS
  申请人：UNIV LELAND STANFORD JUNIOR

  公开号：WO2013123033A1

  公开（公告）日：2013-08-22

  The present disclosure provides DDAH modulators. Thus, the present disclosure provides a method of treating a patient suffering from a disorder characterized by excessive NO production and/or elevated DDAH activity, the method comprising administering to said patient an effective amount of a compound of one of formulae I-X. The present disclosure also provides a pharmaceutical composition comprising a compound of one of formulae I-X.
• [EN] DIMETHYLARGININE DIMETHYLAMINOHYDROLASE INHIBITORS AND METHODS OF USE THEREOF<br/>[FR] INHIBITEURS DE DIMÉTHYLARGININE DIMÉTHYLAMINOHYDROLASE ET LEURS PROCÉDÉS D'UTILISATION
  申请人：UNIV LELAND STANFORD JUNIOR

  公开号：WO2014160947A1

  公开（公告）日：2014-10-02

  The present disclosure provides DDAH modulators. Thus, the present disclosure provides a method of treating a patient suffering from a disorder characterized by excessive NO production and/or elevated DDAH activity, the method comprising administering to said patient an effective amount of a compound of one of formulae I-X. The present disclosure also provides a pharmaceutical composition comprising a compound of one of formulae I-X.
• Direct Phosphorylation of Benzothiazoles and 4-Methyltthiazole
  作者：Igor V. Komarov、Aleksandr V. Strizhak、Mikhail Yu. Kornilov、Evgeniy Zarudnitskiy、Andrey A. Tolmachev

  DOI：10.1080/00397910008087315

  日期：2000.1

  Simple procedures for preparation of 2-(4-methylthiazolyl) dichlorophosphine and wide variety of 2-phosphorylated benzothiazoles are reported. Efficient promoters and catalysts were found for the key transformation, direct phosphorylation of the heterocyclic compounds by PCl3 (PBr3 as a promoter) or by P(V) acid chlorides (HgCl2 as a catalyst).